Scientific Industries, Inc. (SCND)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Scientific Industries, Inc. (SCND) trades at $0.70 with AI Score 52/100 (Grade B). Scientific Industries, Inc. designs, manufactures, and markets laboratory equipment and bioprocessing products. Market cap: $8.35M, Sector: Technology.
Price live · AI analysis from Mar 15, 2026Analyst Coverage for SCND: SCND does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SCND against Technology peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
SCND: 2/7 perspectives are bullish. Dominant signal: Ken Griffin bearish.
How is this calculated? →Scientific Industries, Inc. (SCND) Technology Profile & Competitive Position
Scientific Industries, Inc. specializes in standard benchtop laboratory equipment, weight and measurement solutions, and bioprocessing systems, catering to research institutions and pharmaceutical companies. Operating in the scientific and technical instruments sector, the company distinguishes itself through its Genie and Torbal brands, offering a range of mixers, shakers, and scales.
What Is the Investment Thesis for SCND?
Scientific Industries, Inc. presents a niche investment opportunity within the scientific and technical instruments sector. The company's diverse product range, including its Genie and Torbal brands, caters to a stable customer base in research and pharmaceutical industries. However, with a market capitalization of $8.35M and a negative profit margin of -11.7%, the company faces challenges in achieving profitability. A debt-to-equity ratio of 6.58 indicates a reliance on debt financing. Key catalysts for growth include expanding its bioprocessing systems offerings and increasing e-commerce sales. Potential risks include competition from larger players and the need for continuous innovation to maintain market relevance.
Based on FMP financials and quantitative analysis
SCND Key Highlights
- Market Cap of $8.35M reflects its small size within the scientific instruments market.
- Gross Margin of 42.8% indicates a solid ability to control production costs, though this needs to translate to overall profitability.
- Negative Profit Margin of -11.7% highlights the need for improved operational efficiency and cost management.
- Debt-to-Equity Ratio of 6.58 suggests a high level of financial leverage, which could pose risks if revenue growth does not materialize.
- Beta of 0.38 indicates lower volatility compared to the broader market, potentially appealing to risk-averse investors.
Who Are SCND's Competitors?
SCND is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| DHR Danaher Corporation | $193.75 | -2.11% | $137.13B | 69 |
| TMO Thermo Fisher Scientific Inc. | $516.82 | -1.26% | $192.06B | 61 |
| WAT Waters Corporation | $378.90 | -0.10% | $24.70B | 63 |
| CWB State Street SPDR Bloomberg Convertible Securities ETF | $105.34 | +0.92% | $4.62B | 47 |
| TDV ProShares - S&P Technology Dividend Aristocrats ETF | $100.89 | +1.33% | $293.21M | 47 |
| DAUG FT Vest U.S. Equity Deep Buffer ETF - August | $46.97 | +0.26% | $363.40M | 47 |
| KSTR KraneShares SSE STAR Market 50 Index ETF | $28.75 | +2.00% | $67.07M | 47 |
| FEDDX Fidelity Emerging Markets Discovery Fd | $22.90 | +0.62% | $1.51B | 47 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SCND's Key Strengths?
- Established brands (Genie and Torbal).
- Specialized product offerings.
- Long-standing customer relationships.
- Proprietary technology in bioprocessing.
What Are SCND's Weaknesses?
- Small market capitalization.
- Negative profit margin.
- High debt-to-equity ratio.
- Limited geographic presence.
What Could Drive SCND Stock Higher?
- Expansion of bioprocessing systems product line to meet growing demand in the biotechnology and pharmaceutical industries.
- Increasing e-commerce sales through enhanced online platform and digital marketing efforts.
- Strategic partnerships with universities and research institutions to drive innovation and product adoption.
- Geographic expansion into the Asia-Pacific region to capitalize on growth opportunities.
- Investment in research and development to introduce new and innovative products.
What Are the Key Risks for SCND?
- Financial-distress signal — its Altman Z-Score of -1.56 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-10.3%) — the business is not currently generating profit on shareholder capital.
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Competition from larger players with greater resources and market share.
- Technological obsolescence due to rapid advancements in laboratory equipment and bioprocessing systems.
- Economic downturns affecting R&D spending by universities and pharmaceutical companies.
- Regulatory changes in the pharmaceutical industry impacting demand for certain products.
- High debt-to-equity ratio posing financial risks if revenue growth does not materialize.
What Are the Growth Opportunities for SCND?
- Expansion of Bioprocessing Systems: Scientific Industries can capitalize on the growing demand for bioprocessing systems in the biotechnology and pharmaceutical industries. The global bioprocessing market is projected to reach $44.6 billion by 2027, offering a significant growth opportunity. By enhancing its product offerings and expanding its customer base in this segment, Scientific Industries can drive revenue growth and improve profitability.
- E-commerce Sales Growth: Increasing direct sales through e-commerce channels can improve profit margins and expand market reach. The global e-commerce market is expected to continue its upward trajectory, providing Scientific Industries with a cost-effective way to reach end-users directly. Investing in its online platform and digital marketing efforts can drive significant sales growth.
- Strategic Partnerships: Forming strategic partnerships with universities and research institutions can provide access to new technologies and markets. Collaborating on research projects and offering customized solutions can strengthen customer relationships and drive innovation. These partnerships can also lead to increased product adoption and revenue generation.
- Geographic Expansion: Expanding into new geographic markets, particularly in Asia-Pacific, can drive revenue growth. The Asia-Pacific region is experiencing rapid growth in the biotechnology and pharmaceutical industries, creating significant demand for laboratory equipment and bioprocessing systems. Establishing a presence in this region can diversify revenue streams and reduce reliance on existing markets.
- Product Innovation: Investing in research and development to introduce new and innovative products can maintain a competitive edge. Focusing on developing advanced bioprocessing systems and laboratory equipment can attract new customers and drive sales growth. Continuous innovation is crucial for staying ahead of competitors and meeting the evolving needs of the market.
What Opportunities Does SCND Have?
- Expansion of bioprocessing systems.
- Growth in e-commerce sales.
- Strategic partnerships with research institutions.
- Geographic expansion into Asia-Pacific.
What Threats Does SCND Face?
- Competition from larger players.
- Technological obsolescence.
- Economic downturns affecting R&D spending.
- Regulatory changes in the pharmaceutical industry.
What Are SCND's Competitive Advantages?
- Established brands (Genie and Torbal) with a reputation for quality.
- Specialized product offerings in niche segments.
- Long-standing relationships with key customers.
- Proprietary technology in bioprocessing systems.
What Does SCND Do?
Scientific Industries, Inc., founded in 1954 and headquartered in Bohemia, New York, designs, manufactures, and markets a range of laboratory equipment, weight and measurement solutions, and bioprocessing systems. The company's products are utilized across various industries, including universities, pharmaceutical companies, national laboratories, and medical device manufacturers, for research purposes. Its product portfolio includes vortex mixers, various mixers and shakers under the Genie brand, which are designed to mix the contents of test tubes, beakers, and other containers. The company also offers multi-purpose rotators and rockers, as well as magnetic stirrers. Under the Torbal brand, Scientific Industries provides pharmacy, laboratory, and industrial digital scales, moisture analyzers, mechanical and automated pill counters, force gauges, and test stands products. Additionally, the company offers bioprocessing systems, including cell growth quantifiers, liquid injection systems, coaster systems, flow-through cells, multi-parameter sensors, and dissolved oxygen sensor pills. Scientific Industries sells its products through laboratory equipment distributors and directly to end-users via e-commerce, with operations spanning the United States, Germany, and other international markets.
What Products and Services Does SCND Offer?
- Designs and manufactures standard benchtop laboratory equipment.
- Offers weight and measurement solutions under the Torbal brand.
- Provides bioprocessing systems for cell growth and monitoring.
- Sells vortex mixers and shakers under the Genie brand.
- Offers digital scales, moisture analyzers, and pill counters.
- Provides multi-parameter sensors and dissolved oxygen sensor pills.
- Markets products to universities, pharmaceutical companies, and research labs.
How Does SCND Make Money?
- Designs, manufactures, and sells laboratory equipment and bioprocessing systems.
- Generates revenue through direct sales to end-users and distributors.
- Offers a range of products under the Genie and Torbal brands.
- Focuses on serving the research and pharmaceutical industries.
What Industry Does SCND Operate In?
Scientific Industries, Inc. operates in the scientific and technical instruments industry, a sector characterized by continuous innovation and demand from research institutions, pharmaceutical companies, and healthcare providers. The market is competitive, with larger players like Thermo Fisher Scientific and Danaher Corporation dominating. Scientific Industries focuses on niche segments with its benchtop laboratory equipment and bioprocessing systems. The industry is expected to grow, driven by increasing R&D spending and advancements in biotechnology and pharmaceuticals.
Who Are SCND's Key Customers?
- Universities and research institutions
- Pharmaceutical companies
- National laboratories
- Medical device manufacturers
Company Profile
Scientific Industries, Inc. operates in the Hardware, Equipment & Parts industry within the Technology sector. It is headquartered in Bohemia, US. The company is led by CEO Helena R. Santos. SCND has traded publicly since 1994.
F-Score 1/9Financial Health
Scientific Industries, Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -1.56 places it in the distress zone, a signal of elevated financial risk.
ROE -10%Key Financial Metrics
Return on equity for Scientific Industries, Inc. stands at -10.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.3%, showing how much profit it generates from its asset base. A current ratio of 6.22 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -14.9%, the inverse of the P/E and a quick read on earnings relative to price.
SCND Valuation & Market Position
With a $8.35M market cap, Scientific Industries, Inc. sits in the micro-cap segment of the market. Relative to its peer group, SCND's quantitative score of 52/100 is roughly in line with the peer average of 57/100.
SCND Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Established brands (Genie and Torbal).
- Specialized product offerings.
- Long-standing customer relationships.
- Proprietary technology in bioprocessing.
Bear Case
- Small market capitalization.
- Negative profit margin.
- High debt-to-equity ratio.
- Limited geographic presence.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
SCND Latest News
No recent news available for SCND.
SCND Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SCND.
Price Targets
Wall Street price target analysis for SCND.
SCND MoonshotScore
What does this score mean?
The MoonshotScore rates SCND's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Scientific & Technical InstrumentsSCND OTC Market Information
The OTCQB Venture Market is the middle tier of the over-the-counter (OTC) market for U.S. companies. It is distinguished from the Pink market by requiring companies to be current in their reporting, undergo an annual verification process, and meet a minimum bid price test. While it offers more visibility than the Pink market, it does not have the stringent listing requirements of exchanges like the NYSE or NASDAQ, resulting in higher risk.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Liquidity: OTC stocks generally have lower trading volumes, which can make it difficult to buy or sell shares quickly.
- Information Availability: While SCND maintains current disclosure, the level of scrutiny and information available may be less than that of exchange-listed companies.
- Price Volatility: OTC stocks can be more susceptible to price swings due to lower trading volumes and market capitalization.
- Regulatory Oversight: OTC markets have less regulatory oversight compared to major exchanges, increasing the risk of fraud or manipulation.
- Delisting Risk: Failure to meet OTCQB continued listing requirements could result in delisting and further reduced liquidity.
- Verify the company's financial statements and SEC filings.
- Research the management team and their track record.
- Assess the company's competitive position in its industry.
- Evaluate the company's growth prospects and potential catalysts.
- Understand the risks associated with investing in OTC stocks.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Current Disclosure Status: Maintaining current reporting requirements on the OTCQB market.
- Established Business Operations: Scientific Industries has been in operation since 1954.
- Audited Financial Statements: Publicly available financial statements provide some level of transparency.
- OTCQB Listing: Being listed on the OTCQB market indicates a higher level of compliance compared to the Pink market.
- Positive Gross Margin: A gross margin of 42.8% suggests a viable business model.
Common Questions About SCND (Technology)
What does Scientific Industries, Inc. do?
Scientific Industries, Inc. designs, manufactures, and markets a range of laboratory equipment, weight and measurement solutions, and bioprocessing systems. Its products, sold under the Genie and Torbal brands, are used by universities, pharmaceutical companies, and medical device manufacturers for research purposes. The company operates in the United States, Germany, and internationally, selling through distributors and directly to end-users via e-commerce. Its focus is on providing reliable and innovative tools for the scientific community.
What do analysts say about SCND stock?
As of March 15, 2026, formal analyst ratings for Scientific Industries, Inc. (SCND) are limited due to its small market capitalization and OTCQB listing. Investors should focus on the company's financial performance, including its gross margin of 42.8% and negative profit margin of -11.7%. Growth considerations include expansion of its bioprocessing systems and e-commerce sales. The high debt-to-equity ratio of 6.58 warrants careful monitoring.
What are the main risks for SCND?
The primary risks for Scientific Industries, Inc. include intense competition from larger companies in the scientific instruments sector, the potential for technological obsolescence, and the impact of economic downturns on R&D spending. The company's high debt-to-equity ratio also poses a financial risk. Furthermore, as an OTCQB-listed company, SCND faces risks related to liquidity and regulatory oversight compared to exchange-listed companies.
How exposed is Scientific Industries, Inc. to technology disruption risks?
Scientific Industries, Inc. faces moderate exposure to technology disruption risks. The scientific and technical instruments industry is characterized by continuous innovation, requiring the company to invest in research and development to stay competitive. Failure to adapt to emerging technologies and evolving customer needs could lead to market share loss. Continuous monitoring of industry trends and strategic investments in innovation are crucial for mitigating this risk.
What is Scientific Industries, Inc.'s competitive position in the tech sector?
Scientific Industries, Inc. occupies a niche position in the tech sector, focusing on benchtop laboratory equipment, weight and measurement solutions, and bioprocessing systems. While it lacks the scale and resources of larger competitors like Danaher and Thermo Fisher Scientific, its established brands (Genie and Torbal) and specialized product offerings provide a competitive advantage in specific segments. The company's ability to maintain customer relationships and innovate will be key to sustaining its position.
What are the key factors to evaluate for SCND?
Scientific Industries, Inc. (SCND) holds an AI score of 52/100 (moderate). Not financial advice.
How frequently does SCND data refresh on this page?
SCND prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven SCND's recent stock price performance?
Scientific Industries, Inc. (SCND) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established brands (Genie and Torbal). See the News tab for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC analysis is based on general characteristics of the OTCQB market.
- Analyst opinions are limited due to the company's size and OTC listing.